William Greenhalf

Development of Multiple Reaction Monitoring techniques for the quantification of biomarkers of pancreatic cancer

John F. Timms, Elliott, Claire Jenkinson, 2011 .

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Robert C. Green, Andrew J. Saykin, Liana G. Apostolova, 2012, Nature Genetics.

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

John R. Mackey, Fiona Campbell, David Goldstein, 2014, Journal of the National Cancer Institute.